Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Prasad

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Biochemical Medicine|February 1, 1974
3-O-methyl metabolites of catecholamines: automated fluorometric assay and their plasma levels in patients receiving levodopa and carbidopaA L Prasad, S Fahn
Biochemical Medicine|June 1, 1982
A semiautomated method for the rapid determination of dopa: comparison of plasma and erythrocyte-dopa concentration in levodopa-treated patientsA L Prasad, S Fahn
Neurobehavioral Toxicology and Teratology|September 1, 1984
Effects of chronic manganese intake on the levels of biogenic amines in rat brain regionsE Bonilla, A L Prasad
Journal of Neurochemistry|December 1, 1973
Fluorometric determination of homovanillic acid in the presence of other acid metabolites of catecholaminesA L Prasad, S Fahn
Dermatologica|January 1, 1984
A clinical profile of donovanosis in a non-endemic areaV N Sehgal, A L Prasad
International Journal of Dermatology|January 1, 1986
Donovanosis. Current conceptsV N Sehgal, A L Prasad
Life Sciences|January 1, 1988
Huntington's disease: studies on brain free amino acidsE Bonilla, A L Prasad, A Arrieta
Analytical Biochemistry|April 1, 1972
A reliable and simple method for simultaneous determination of DOPA and 3-O-methyldopa in plasma and brainS Fahn, A L Prasad, R Delesie
Biochemical Medicine|September 1, 1975
Dopamine: a sensitive automated assay and examples of levodopa therapyA L Prasad, S Fahn, W P Isgreen
Biochemical Pharmacology|April 1, 1979
Effect of a catechol-O-methyl transferase inhibitor, U-0521, with levodopa administrationS Fahn, R Comi, S R Snider, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Biochemical Medicine|February 1, 1974
3-O-methyl metabolites of catecholamines: automated fluorometric assay and their plasma levels in patients receiving levodopa and carbidopaA L Prasad, S Fahn
Biochemical Medicine|June 1, 1982
A semiautomated method for the rapid determination of dopa: comparison of plasma and erythrocyte-dopa concentration in levodopa-treated patientsA L Prasad, S Fahn
Neurobehavioral Toxicology and Teratology|September 1, 1984
Effects of chronic manganese intake on the levels of biogenic amines in rat brain regionsE Bonilla, A L Prasad
Journal of Neurochemistry|December 1, 1973
Fluorometric determination of homovanillic acid in the presence of other acid metabolites of catecholaminesA L Prasad, S Fahn
Dermatologica|January 1, 1984
A clinical profile of donovanosis in a non-endemic areaV N Sehgal, A L Prasad
International Journal of Dermatology|January 1, 1986
Donovanosis. Current conceptsV N Sehgal, A L Prasad
Life Sciences|January 1, 1988
Huntington's disease: studies on brain free amino acidsE Bonilla, A L Prasad, A Arrieta
Analytical Biochemistry|April 1, 1972
A reliable and simple method for simultaneous determination of DOPA and 3-O-methyldopa in plasma and brainS Fahn, A L Prasad, R Delesie
Biochemical Medicine|September 1, 1975
Dopamine: a sensitive automated assay and examples of levodopa therapyA L Prasad, S Fahn, W P Isgreen
Biochemical Pharmacology|April 1, 1979
Effect of a catechol-O-methyl transferase inhibitor, U-0521, with levodopa administrationS Fahn, R Comi, S R Snider, et al.
Pageof 2